Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 436 AL 450

Microfluidic-Based Technologies for Crossing the Blood-Brain Barrier Against Alzheimer's Disease: Novel Strategies and Challenges

Ferrari I, Limiti E, Giannitelli SM, Trombetta M, Rainer A, D'Amelio M, La Barbera L, Gori M.

Int J Mol Sci. 2025 Sep 27;26(19):9478. doi: 10.3390/ijms26199478.

Microbial links to Alzheimer's disease

Cornitius CP, Perez EK, Lee SC.

PLoS Pathog. 2025 Oct 23;21(10):e1013599. doi: 10.1371/journal.ppat.1013599. eCollection 2025 Oct.

Cuproptosis: mechanisms and links with Alzheimer's disease

Zheng N, Zhou Q, Chen Z, Xie L, Yang X, Chen Z, Wang F, Sun Q, Du J, Lin J, Li L, Li B.

J Neurophysiol. 2025 Dec 1;134(6):1853-1876. doi: 10.1152/jn.00370.2025. Epub 2025 Oct 27.

A Neural-Glial Model of the ApoE-SORT1-FABP7 Axis Tied to Sleep Disruption and Alzheimer's Disease Pathophysiology

Flores CC, Lee Y, Davis CJ, Solverson P, Gerstner JR.

Biomolecules. 2025 Oct 10;15(10):1432. doi: 10.3390/biom15101432.

Mitophagy in Alzheimer's disease and its potential as a therapeutic target

Wei J, Xiao T, Lyu J, Zhao Y, Zhang Y, Du X, He Y, Zhao M, Yang X, Yao Y, Ruan J, Liu K, Zhang L, Zhao J, Xu J, Wang B.

Neurobiol Dis. 2025 Dec;217:107162. doi: 10.1016/j.nbd.2025.107162. Epub 2025 Oct 28.

[Research progress in the role of HCN channels in Alzheimer's disease]

Li XJ, Zheng B, Lan P, Zhang WX, Li YP, He Z.

Sheng Li Xue Bao. 2025 Oct 25;77(5):867-875. doi: 10.13294/j.aps.2025.0078.

The Energetic Collapse of the Alzheimer's Brain: Metabolic Inflexibility Across Cells and Networks

Constantino NJ, Ashley CC, Macauley SL.

J Neurochem. 2025 Nov;169(11):e70294. doi: 10.1111/jnc.70294.

Targeted Nanoparticles for Drug Delivery Across the Blood-Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review

Kochman U, Sitka H, Kuźniar J, Czaja M, Kozubek P, Beszłej JA, Leszek J.

Mol Neurobiol. 2025 Nov 19;63(1):75. doi: 10.1007/s12035-025-05417-z.

Progress and Perspectives on the Estrogen-Microbiota-Brain Axis in Alzheimer's Disease

Wang M, Zeng Y, Jin Y, Wu J, Li J.

Neurochem Res. 2025 Nov 26;51(1):3. doi: 10.1007/s11064-025-04613-6.

Unraveling tau's fold: Structural dynamics in Alzheimer's pathogenesis

Montaño S, Luna-Viramontes NI, Cuevas E, Martínez-Cuevas PP, Pacheco-Herrero M, León-López L, Armenta AD, Luna-Muñoz J.

Adv Protein Chem Struct Biol. 2025;148:29-56. doi: 10.1016/bs.apcsb.2025.08.005. Epub 2025 Sep 2.

Beyond Structure: The Interplay of Bone and Brain During Alzheimer's Disease

Pinnamaneni A, Akkiraju A, Park HI, Ch V RSR, Ayalasomayajula V, Bandela M, Kaipa S, Khosla S, Zeineh M, Suryadevara V; Alzheimer's Disease Neuroimaging Initiative.

Compr Physiol. 2025 Dec;15(6):e70075. doi: 10.1002/cph4.70075.

Unraveling the Significance of Fecal MicroRNA Profile in Alzheimer's Disease

Katuwawala K, Bharadwaj P, Martins I, De Silva BGDNK, Ho V, Dissanayake A, Martins RN, Fernando WMADB.

Mol Neurobiol. 2025 Dec 22;63(1):319. doi: 10.1007/s12035-025-05626-6.

An overview of gene and cell therapy approaches for Alzheimer's disease

Heidari Z, Zakaee A, Vafadar A, Alavimanesh S, Charami H, Jamali Z, Jahromi AH, Rakhsha A, Savardashtaki A.

Metab Brain Dis. 2025 Dec 26;41(1):10. doi: 10.1007/s11011-025-01763-y.

Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics

Arar S, Haque MA, Kayed R.

Proteins. 2025 Aug;93(8):1314-1329. doi: 10.1002/prot.26561. Epub 2023 Aug 2.

Entwined processes in Alzheimer's disease: Brain cellular senescence and Alzheimer's disease pathology

Li W, Han Y, Wang P, Song Q.

Alzheimers Dement. 2025 Oct;21(10):e70803. doi: 10.1002/alz.70803.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias